Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

A study suggests that those under age 65 may need no restrictions at all, but more data would help clarify the issue.